United Orthopedic Corporation held an investor conference on Nov 27. Chairman Lin Yen-sheng stated that despite a high baseline from doubled revenue over the past three years, the company expects approximately 20% revenue growth in 2026. To support this, United will initiate the construction of Kaohsiung Plant II, with production expected to commence by 2028. Growth drivers will primarily stem from Europe, the Americas, Japan, and new product launches.
Read more
